FMR CORP 13D/13G Filings for Mirati Therapeutics, Inc. (MRTX)

FMR CORP 13D and 13G filings for Mirati Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-09
09:22 am
Sale		 2022-02-08 13G Mirati Therapeutics, Inc.
MRTX		 FMR CORP 2,735,803
4.954%		 -42,554decrease
(-1.53%)		 Filing
2021-02-08
10:27 am
Purchase		 2021-02-05 13G Mirati Therapeutics, Inc.
MRTX		 FMR CORP 2,778,357
5.457%		 762,537increase
(+37.83%)		 Filing